The University of Oxford has paused administering doses of the COVID-19 vaccine it developed with AstraZeneca PLC in a small U.K. study to test the shot in children and teenagers, pending further information about rare blood-clotting issues in adults who have received it, the Wall Street Journal reported on Tuesday.
Trending:
Oxford pauses dosing in trial of AstraZeneca COVID-19 vaccine in children, teenagers - WSJ